Related Experiment Videos
The human glucocerebrosidase gene and pseudogene: structure and evolution.
M Horowitz1, S Wilder, Z Horowitz
1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Isreal.
Genomics
|January 1, 1989
Summary
Researchers sequenced the human beta-glucocerebrosidase gene and its pseudogene, identifying key promoter elements. This genetic information aids in developing molecular diagnostics for Gaucher disease.
Area of Science:
- Genetics
- Molecular Biology
- Human Gene Sequencing
Background:
- Beta-glucocerebrosidase (GBA) gene mutations are linked to Gaucher disease.
- Understanding the GBA gene structure and regulatory elements is crucial for diagnostic and therapeutic advancements.
Purpose of the Study:
- To report the complete sequence of the human beta-glucocerebrosidase gene and its pseudogene.
- To identify and characterize the promoter region of the GBA gene.
- To provide sequence data for developing molecular diagnostic methods for Gaucher disease.
Main Methods:
- Gene sequencing of the human beta-glucocerebrosidase gene and its pseudogene.
- Identification of TATA and CAT-like boxes in the promoter region.
- Functional analysis of the promoter using a chloramphenicol acetyltransferase (CAT) reporter gene assay in transfected cells.
Main Results:
- The human beta-glucocerebrosidase gene comprises 11 exons.
- The promoter region contains functional TATA and CAT-like boxes, directing tissue-specific expression.
- A homologous pseudogene was identified, with significant differences in introns due to Alu sequence insertions and a deletion in exon 9.
Conclusions:
- The characterized GBA gene promoter is functional and exhibits tissue-specific expression.
- Sequence data of the GBA gene and pseudogene provide a foundation for Gaucher disease molecular diagnostics.
- The identified structural differences in the pseudogene offer insights into gene evolution.